Nirsevimab-alip as a New Option to Prevent Respiratory Syncytial Virus
Are you a Pharmacy Tech? Check out the Pharmacy Tech version of this course.
Respiratory syncytial virus is a respiratory virus that typically presents with mild cold-like symptoms; however, some population groups are at increased risk of developing severe symptoms or dying from this virus. Children under five years of age are particularly at risk of severe illness, hospitalization, or death, driving the need for better preventive approaches for this age group. Nirsevimab-alip has been recently approved to prevent severe respiratory syncytial virus in infants and children under 24 months. This vaccine may be used as part of a prevention plan during the viral season. This course reviews the prevalence and risk factors of the virus, its prevention (including immunization using nirsevimab-alip), symptom management, and the impact pharmacists and pharmacy staff may have in caring for pediatric patients at risk of severe respiratory syncytial virus symptoms.
Identify individuals who are at high risk of severe disease from the respiratory syncytial virus (RSV).
Discuss strategies to prevent RSV.
Identify individuals who are indicated to receive nirsevimab-alip.
Outline the dosing and administration guidelines for nirsevimab-alip.
II. Prevalence of Respiratory Syncytial Virus
III. Risk Factors for RSV
IV. Transmission of RSV
V. RSV Symptoms and Their Management
VI. Prevention of RSV
2. Dosing and Administration
3. Mechanism of Action
4. Storage and Handling
5. Contraindications, Warnings, and Precautions
6. Adverse Reactions
7. Drug Interactions
8. Specific Populations
10. Clinical Studies
VIII. Interdisciplinary Approach and Collaboration
- Read the course objectives and faculty planner disclosure
- Read the course material
- Complete the post-test with a minimum score of 70% and complete the course evaluation form.
- Results are automatically submitted to CPE Monitor
Faculty Planner Disclosure
The following individuals were involved in developing this activity: Amanda Mayer, PharmD, and Pamela Sardo, PharmD, BS. Pamela Sardo was an employee of Rhythm Pharmaceuticals until March 2022 and has no conflicts of interest or relationships regarding the subject matter discussed. There are no financial relationships relevant to this activity to report or disclose by any of the individuals involved in the development of this activity.
Unlabeled Use Disclosures
The information provided in this course is general in nature and it is solely designed to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant’s professional practice, including but not limited to patient assessment, diagnosis, treatment and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals, including pharmacists and pharmacy technicians, must consult with their employer, healthcare facility, hospital, or other organization, for guidelines, protocols, and procedures they are to follow. The information provided in this course does not replace those guidelines, protocols, and procedures but is for academic purposes only, and this course’s limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses are constantly changing, and any person taking this course understands that such person must make an independent review of medication information prior to any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of RxCe.com LLC. RxCe.com LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course, or course material.
Computer Hardware/Software Requirements
Please ensure the device you plan to use meets these requirements and specifications:
- Operating System: Windows 7,8,10, or 11 /Mac OS X 10.9 or later/iOS/Android
- Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
- A connection to the internet
- For Live Webinars or Conferences: GoToWebinar application for iOS, Android, Mac, or PC. You cannot 'call into' a live conference.
- Target Audience: Pharmacist
- Contact Hours: 1.5 (0.15 CEUs)
- Activity Release Date: 1/8/2024
- Activity Expiration Date: 1/8/2027
- Activity Type: Knowledge
- UAN: 0669-0000-24-001-H06-P
- Topic: Immunizations
- CeBroker Number: 20-1158614
Preview the Materials:
RxCe.com, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.